Back to CDP-Choline

Timing & pharmacokinetics

How long does CDP-Choline take to work?

CDP-Choline typically begins to take effect 60 minutes after dosing in healthy adults. Standard supplement onset, take an hour before the target task window.

Onset

60 min

Half-life

56h

Duration

Timing

AM/midday

Key facts

typical dose
250–500 mg
dose frequency
1-2 doses
timing
AM/midday
with food
optional
onset
60 minutes
half-life
56 hours
safety score
5/5
evidence grade
A
class
cholinergic
PubMed citations
420
legal status (US)
Over-the-counter
legal status (UK)
Over-the-counter
legal status (EU)
Over-the-counter
legal status (AU)
Over-the-counter
primary mechanism
Hydrolysed into choline and cytidine in the gut.

Onset window

Peak plasma concentration of CDP-Choline is typically reached around 90120 minutes post-dose in fasted healthy adults. The subjective effect window aligns closely with the peak in well-absorbed compounds; for slow-absorbed botanicals it may lag by 30–90 minutes.

Food effect: Food has only modest effect on CDP-Choline onset. Take with or without food depending on GI tolerance.

Half-life and dosing frequency

Very long 56-hour half-life, accumulates with daily use; consider every-other-day dosing or weekly cycling.

Acute vs. chronic effect

Some nootropics work the first time you take them (CDP-Choline fits this pattern). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges.

If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.

Mechanism, safety, and citations for CDP-Choline are on the main reference page, see CDP-Choline. For full dose protocol see CDP-Choline dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.

Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.